Literature DB >> 11871822

Small intestinal bleeding, secondary to metastatic malignant fibrous histiocytoma of the rib: report of a case.

Masaya Tamura1, Makoto Oda, Yasuhiko Ohta, Kenji Omura, Akitaka Nonomura, Go Watanabe.   

Abstract

Malignant fibrous histiocytoma (MFH) is an aggressive bone tumor with a high propensity for metastasis. We describe herein the case of a 73-year-old man found to have MFH of the rib with a metastasis in the small intestine. The patient complained of gastrointestinal bleeding as the first symptom. Computed tomography imaging demonstrated a tumor in the left chest wall, and abdominal magnetic resonance imaging revealed thickening of the wall in the internal cavity of the small intestine. Histopathological and immunohistochemical examination confirmed that the tumor in the small intestine was an MFH that had metastasized from the rib.

Entities:  

Mesh:

Year:  2002        PMID: 11871822     DOI: 10.1007/s595-002-8117-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  3 in total

1.  Peritoneal dissemination from malignant fibrous histiocytoma of the buttock: unusual metastases from a rare tumor.

Authors:  Jung-Wan Yoo; Dae Ho Lee; Ho June Song; Jin-Hee Ahn; Sang-We Kim; Cheolwon Suh; Jung Shin Lee
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

Review 2.  Successful treatment of malignant fibrous histiocytoma originating in the chest wall: report of a case.

Authors:  Naoya Yoshida; Nobutomo Miyanari; Yutaka Yamamoto; Hiroshi Egami
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation.

Authors:  Abbas Agaimy; Andreas Gaumann; Josef Schroeder; Wolfgang Dietmaier; Arndt Hartmann; Ferdinand Hofstaedter; Peter H Wünsch; Thomas Mentzel
Journal:  Virchows Arch       Date:  2007-09-14       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.